---
title: 'Novel time-synchronized immune-guided partial tumor irradiation: Proof of
  principle trial'
date: '2024-07-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39069088/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240729181610&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: This study highlights the profound impact PTI can have
  on a highly palliative patient cohort previously deemed beyond therapeutic hope.
  With 41 % of these patients still alive after a median follow-up of 50 months, PTI
  offers a potential lifeline for those facing advanced, treatment-resistant cancers.
  This approach generated also distant immunogenic anti-tumor responses, offering
  a promising new avenue for the treatment of advanced ...'
disable_comments: true
---
CONCLUSIONS: This study highlights the profound impact PTI can have on a highly palliative patient cohort previously deemed beyond therapeutic hope. With 41 % of these patients still alive after a median follow-up of 50 months, PTI offers a potential lifeline for those facing advanced, treatment-resistant cancers. This approach generated also distant immunogenic anti-tumor responses, offering a promising new avenue for the treatment of advanced ...